Literature DB >> 31353782

Occurrence of complete heart block associated with acute renal infarction.

Yi-Ching Su1, Chun-Hsien Hsu1,2,3.   

Abstract

Complete heart block (CHB) and acute renal infarction (ARI) are both uncommon diseases and seldom encountered in the clinical practice. We describe a rare case of pre-existing left bundle branch block, presenting simultaneously with CHB and ARI. The possible mechanism depends on prior presence of either CHB or ARI. If ARI occurs first, severe pain and embolism may enhance the vagal tone resulting in decrease in the heart rate and transient intraventricular conduction interruption, which subsequently causes CHB. The opposite scenario, CHB preceding ARI, is also possible. CHB can be physiologic and transient, with higher risk of development in the circumstance of pre-existing conduction system disturbances. Patients with CHB are predisposed to formation of thrombi and thromboemboli, giving rise to ARI. In conclusion, awareness and timely identification of the clinical manifestations of these two diseases may facilitate early diagnosis and prompt management.
© 2019 Wiley Periodicals, Inc.

Entities:  

Keywords:  atrioventricular conduction block; bundle branch block; complete heart block; renal infarction

Mesh:

Year:  2019        PMID: 31353782      PMCID: PMC6931725          DOI: 10.1111/anec.12674

Source DB:  PubMed          Journal:  Ann Noninvasive Electrocardiol        ISSN: 1082-720X            Impact factor:   1.468


  8 in total

1.  Syncope and complete atrioventricular block related to pulmonary thromboembolism.

Authors:  Jorge Elias; Ricardo Kuniyoshi; Bruno Moulin; Fabíola Cunha; Eduardo Castro; Alfredo Nunes; Vitor Barreto; Alaôr Queiroz; Felipe Moysés
Journal:  Arq Bras Cardiol       Date:  2004-11-11       Impact factor: 2.000

2.  Effect of continuous enhanced vagal tone on atrioventricular nodal and sinoatrial nodal function in humans.

Authors:  R L Page; A S Tang; E N Prystowsky
Journal:  Circ Res       Date:  1991-06       Impact factor: 17.367

3.  Occurrence of complete heart block associated with acute renal infarction.

Authors:  Yi-Ching Su; Chun-Hsien Hsu
Journal:  Ann Noninvasive Electrocardiol       Date:  2019-07-29       Impact factor: 1.468

4.  Electrocardiographic findings in pulmonary embolism.

Authors:  Elaine Boey; Swee-Guan Teo; Kian-Keong Poh
Journal:  Singapore Med J       Date:  2015-10       Impact factor: 1.858

5.  Renal Complications in Patients with Renal Infarction: Prevalence and Risk Factors.

Authors:  Jae Hyun Kwon; Bum Jin Oh; Sang Ook Ha; Dae Yong Kim; Han Ho Do
Journal:  Kidney Blood Press Res       Date:  2016-11-21       Impact factor: 2.687

Review 6.  Procoagulant activity in hemostasis and thrombosis: Virchow's triad revisited.

Authors:  Alisa S Wolberg; Maria M Aleman; Karin Leiderman; Kellie R Machlus
Journal:  Anesth Analg       Date:  2011-11-21       Impact factor: 5.108

7.  The prevalence and prognosis of third-degree atrioventricular conduction block: the Reykjavik study.

Authors:  E M Kojic; T Hardarson; N Sigfusson; H Sigvaldason
Journal:  J Intern Med       Date:  1999-07       Impact factor: 8.989

8.  Clinical Characteristics and Outcomes of Renal Infarction.

Authors:  Yun Kuy Oh; Chul Woo Yang; Yong-Lim Kim; Shin-Wook Kang; Cheol Whee Park; Yon Su Kim; Eun Young Lee; Byoung Geun Han; Sang Ho Lee; Su-Hyun Kim; Hajeong Lee; Chun Soo Lim
Journal:  Am J Kidney Dis       Date:  2015-11-04       Impact factor: 8.860

  8 in total
  2 in total

1.  Occurrence of complete heart block associated with acute renal infarction.

Authors:  Yi-Ching Su; Chun-Hsien Hsu
Journal:  Ann Noninvasive Electrocardiol       Date:  2019-07-29       Impact factor: 1.468

2.  Clinically Significant High-Grade AV Block as a Reversible Cause for Acute Kidney Injury in Hospitalized Patients-A Propensity Score Matched Cohort.

Authors:  Aviram Hochstadt; Ido Avivi; Merav Ingbir; Yacov Shacham; Ilan Merdler; Yoav Granot; Sami Viskin; Raphael Rosso; Shmuel Banai; Maayan Konigstein
Journal:  J Clin Med       Date:  2021-05-30       Impact factor: 4.241

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.